A-Alpha Bio: Padma Kodukula

Padma Kodukula has joined A-Alpha Bio as chief business officer. She will be responsible for executing the company's overall corporate and business strategy, in particular the development and expansion of strategic partnerships with pharma and biotech firms. She comes to A-Alpha Bio from Precision NanoSystems, which was acquired by Danaher in June, where she closed various business partnerships. Prior to that, she held business development roles at Human Longevity, Life Technologies, and Prometheus Laboratories. Kodukula holds a PhD in immunology from the University of Chicago and an MBA from San Diego State University.